These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 15805349)

  • 21. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of somatropin for the treatment of short children born small for gestational age.
    Christensen T; Buckland A; Bentley A; Djurhuus C; Baker-Searle R
    Clin Ther; 2010 Jun; 32(6):1068-82. PubMed ID: 20637961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term height gain of prematurely born children with neonatal growth restraint: parallellism with the growth pattern of short children born small for gestational age.
    Finken MJ; Dekker FW; de Zegher F; Wit JM;
    Pediatrics; 2006 Aug; 118(2):640-3. PubMed ID: 16882818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW; Willemsen RH; van der Kaay DC; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of long-term continuous growth hormone treatment of children born small for gestational age.
    Hokken-Koelega A; van Pareren Y; Arends N; Boonstra V
    Horm Res; 2004; 62 Suppl 3():149-54. PubMed ID: 15539818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Growth hormone treatment of short children born small for gestational age].
    Christesen HB; Jensen RB; Birkebaek NH; Hertel NT; Main KM; Mortensen HB; Naeraa RW; Juul A
    Ugeskr Laeger; 2006 Feb; 168(9):889-95. PubMed ID: 16513050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human growth hormone in short children born small for gestational age. German Study Group.
    Butenandt O; Lang G
    J Pediatr Endocrinol Metab; 1997; 10(3):275-82. PubMed ID: 9388818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone treatment strategy for short children born small for gestational age.
    Czernichow P
    Horm Res; 2004; 62 Suppl 3():137-40. PubMed ID: 15539815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone treatment and fat redistribution in children born small for gestational age.
    De Schepper J; Thomas M; Beckers D; Craen M; Maes M; de Zegher F
    J Pediatr; 2008 Mar; 152(3):327-30. PubMed ID: 18280835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal follow-up of height up to five years of age in infants born preterm small for gestational age; comparison to full-term small for gestational age infants.
    Itabashi K; Mishina J; Tada H; Sakurai M; Nanri Y; Hirohata Y
    Early Hum Dev; 2007 May; 83(5):327-33. PubMed ID: 16930872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Growth follow-up of SGA children after 3 years of GH treatment].
    Edouard T; Oliver I; Jouret B; Lounis N; Moulin P; Pienkowski C; Elefterion M; Salles JP; Tauber M
    Arch Pediatr; 2008 Feb; 15(2):115-21. PubMed ID: 18207714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent recombinant growth hormone treatment in short children born small for gestational age: four-year results of a randomized trial of two different treatment regimens.
    Simon D; Leger J; Fjellestad-Paulsen A; Crabbé R; Czernichow P;
    Horm Res; 2006; 66(3):118-23. PubMed ID: 16772718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Height, muscle, fat and bone response to growth hormone in short children with very low birth weight born appropriate for gestational age and small for gestational age.
    Berndt C; Schweizer R; Ranke MB; Binder G; Martin DD
    Horm Res Paediatr; 2014; 82(2):81-8. PubMed ID: 24969628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
    Martin DD; Schweizer R; Schönau E; Binder G; Ranke MB
    Horm Res; 2009; 72(1):38-45. PubMed ID: 19571558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
    van der Kaay DC; Hendriks AE; Ester WA; Leunissen RW; Willemsen RH; de Kort SW; Paquette JR; Hokken-Koelega AC; Deal CL
    Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.